Open Access 01-12-2015 | Case report
Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG
Published in: Experimental Hematology & Oncology | Issue 1/2015
Login to get access